EyePoint, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
EyePoint, Inc. (EYPT) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $33.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2023-03-10
- 2022-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $33.00K.
- 2022-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $64.00K.
- 2022-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $98.00K.
- 2022-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $132.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2022-12-31 | $33.00K 10-K · filed 2023-03-10 |
| 2022-09-30 | $64.00K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $98.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $132.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $166.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | $210.00K 10-Q · filed 2021-11-05 |
| 2021-06-30 | $124.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $155.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $187.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $61.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $74.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $86.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |